Similar Posts

Five faculty members honored in 2024 class of Rogel Scholars
By Paul Avedisian We are thrilled to announce that five faculty members of the Center for RNA Biomedicine have been honored as Rogel Scholars by the Rogel Cancer Center at the University of Michigan. The Rogel Scholars awards program provides support for exceptional faculty dedicated to achieving impact through novel breakthroughs in cancer research – a select…
RNA Symposium March 31 to focus on personalized medicine (University Record)
March 23, 2017 Topic: Health & Medicine, Research Leading researchers in personalized medicine diagnostics, therapeutics and health care with a focus on RNA will gather at the University of Michigan on March 31 for the annual RNA Symposium sponsored by the U-M Center for RNA Biomedicine. RNA (ribonucleic acid) is known as the molecule that…
2021 Symposium – Matching our keynote speakers with their topics
Our 5th Annual Symposium,”Processing RNA,” March 25–26, 2021, 11:00–2:30 pm ET Can you match our speakers with their topics? SYMPOSIUM REGISTRATION Answer SYMPOSIUM DETAILED INFORMATION
RNA Featured Researcher — Monika Franco, Program in Chemical Biology
Monika Franco Ph.D. Candidate Program in Chemical Biology Koutmou Lab What are your research interests? My thesis work is centered around investigating mRNA modifications and how they impact protein translation. Who/what brought you to science? People. People brought me to science. My friends, my family, my professors. It was the idea that…
The RNA Collaborative celebrates its first year of success!
Launched at the initiative of the University of Michigan Center for RNA Biomedicine, and inaugurated on April 22, 2020, with a seminar hosted by the Yale Center for RNA Science and Medicine, the RNA Collaborative Seminar Series is a growing grassroots effort, now supported by the international RNA Society and involving 21 RNA research partners…
RNA research brings hope to 30 million patients
By Elisabeth Paymal Altogether, over 6,800 rare diseases affect an estimated 25 million to 30 million Americans. These patients who suffer from genetic mutations that often occur within the same family, are still nowadays left with few, if any, therapeutic options. However, RNA on-going discoveries and the development of new technology and tools such as…
